STAT3 and cervical carcinoma: Therefore, we suggest that patients with cervical cancer, or even other HPV associated cancers, may benefit from treatment with STAT3 inhibitors, mainly if associated with other treatments, possibly chemo and radiotherapy, but even better combined with immunotherapies that could trigger Th1 immune responses (Figure 7).